Independent Financial Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$568K Buy
+4,607
New +$572K 0.01% 948
2026
Q2
– Sell
-4,919
Closed -$510K – 1608
2026
Q1
$510K Buy
+4,919
New +$520K 0.01% 924
2023
Q4
– Sell
-2,811
Closed -$203K – 994
2023
Q3
$203K Sell
2,811
-53
-2% -$4.06K 0.01% 827
2023
Q2
$217K Sell
2,864
-821
-22% -$62.7K 0.01% 790
2023
Q1
$280K Buy
3,685
+2
+0.1% +$154 0.02% 634
2022
Q4
$289K Buy
3,683
+2
+0.1% +$154 0.02% 569
2022
Q3
$262K Buy
3,681
+152
+4% +$11.3K 0.02% 578
2022
Q2
$265K Buy
3,529
+2
+0.1% +$152 0.03% 538
2022
Q1
$281K Buy
3,527
+1
+0% +$78 0.02% 621
2021
Q4
$286K Buy
3,526
+766
+28% +$60.5K 0.02% 615
2021
Q3
$213K Sell
2,760
-98
-3% -$7.9K 0.02% 646
2021
Q2
$230K Buy
2,858
+125
+5% +$9.93K 0.02% 618
2021
Q1
$216K Buy
+2,733
New +$213K 0.03% 571

Other funds holding PJP

Independent Financial Group's PJP Position: Q3 2026 in Review

Independent Financial Group opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q3 2026: 4,607 shares worth $568K. The stake represents 0.01% of the portfolio and ranks #948 among its holdings. This is a return to the name: Independent Financial Group previously reported a position in PJP as recently as Q1 2026.

Independent Financial Group first reported a position in PJP in Q1 2021 and has held it in 13 quarters since. 10 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

  • Independent Financial Group held 4,607 shares of Invesco Pharmaceuticals ETF worth $568K as of Q3 2026.
  • Invesco Pharmaceuticals ETF was a new Independent Financial Group position in Q3 2026.
  • Invesco Pharmaceuticals ETF made up 0.01% of Independent Financial Group's portfolio in Q3 2026, its #948 holding.
  • Independent Financial Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2021 and has held it in 13 quarters since.
  • 10 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Independent Financial Group's 13F filing for Q3 2026, filed 13 Oct 2026.